Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
2003 ◽
Vol 27
(10)
◽
pp. 893-897
◽
2019 ◽
Vol 55
(2)
◽
pp. 452-460
◽
2018 ◽
Vol 18
(5)
◽
pp. 346-352.e5
◽
2004 ◽
Vol 44
(8)
◽
pp. 873-880
◽
2012 ◽
Vol 53
(7)
◽
pp. 1331-1337
◽